切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2018, Vol. 12 ›› Issue (02) : 75 -79. doi: 10.3877/cma.j.issn.1674-3903.2018.02.007

所属专题: 文献

综述

肝移植受者围手术期镇痛药物的选择与合理应用
饶跃峰1, 张晅2, 王融溶1, 冯智英3, 卢晓阳1, 王伟林4,()   
  1. 1. 310003 杭州,浙江大学医学院附属第一医院药学部
    2. 310003 杭州,浙江大学医学院附属第一医院药学部;225001 扬州,江苏省苏北人民医院药学部
    3. 310003 杭州,浙江大学医学院附属第一医院疼痛科
    4. 310003 杭州,浙江大学医学院附属第一医院肝胆胰外科
  • 收稿日期:2017-06-13 出版日期:2018-05-25
  • 通信作者: 王伟林
  • 基金资助:
    浙江省自然科学基金(LY17H310002)

Selection and rational use of analgesics in perioperative period of liver transplantation

Yuefeng Rao1, Xuan Zhang2, Rongrong Wang1, Zhiying Feng3, Xiaoyang Lu1, Weilin Wang4,()   

  1. 1. Department of Pharmacy, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
    2. Department of Pharmacy, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
    3. Department of Pharmacy, Northern Jiangsu People′s Hospital, Yangzhou 225001, China
    4. Department of Pain Medicine, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
  • Received:2017-06-13 Published:2018-05-25
  • Corresponding author: Weilin Wang
  • About author:
    Corresponding author: Wang Weilin, Email:
引用本文:

饶跃峰, 张晅, 王融溶, 冯智英, 卢晓阳, 王伟林. 肝移植受者围手术期镇痛药物的选择与合理应用[J/OL]. 中华移植杂志(电子版), 2018, 12(02): 75-79.

Yuefeng Rao, Xuan Zhang, Rongrong Wang, Zhiying Feng, Xiaoyang Lu, Weilin Wang. Selection and rational use of analgesics in perioperative period of liver transplantation[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2018, 12(02): 75-79.

肝移植已成为现代医学中治疗终末期肝病的常规手术,近年来在国内外均有长足进步和发展。与肝功能正常的其他经腹手术患者相比,肝移植受者围手术期阿片类药物的需求量更低。术前肝功能水平和手术过程、术后一过性障碍以及手术创伤等均会影响镇痛药物的药物代谢动力学和药物效应动力学。选择合适的药物和剂量有助于获得适宜的麻醉深度及疼痛控制,同时避免过度镇静延长术后机械通气时间的风险,有利于肝移植受者的快速康复。本文对目前肝移植中常用镇痛药物的药物代谢动力学、药物效应动力学及其在肝移植受者中的合理应用及安全性作一综述,为肝移植围手术期疼痛管理提供参考。

Liver transplantation has become a routine surgery for the treatment of end-stage liver disease in modern medicine, great progress and development of surgical techniques have been made world-wide in recent years. Liver transplantation recipients have been reported to have decreased demand for opioid during perioperative period compared with patients who underwent other types of abdominal surgeries without liver disease. Preoperative liver function, process of transplantation, transient hepatic dysfunction after surgery and surgical trauma may alter the pharmacokinetic and pharmacodynamic of different analgesic. Proper medication and dosage selection can help to obtain adequate anesthetic depth and pain control, and reduce the risk of prolongation of mechanical ventilation caused by over-sedation, and is also conducive to rehabilitation of patients. This review mainly focuses on the pharmacokinetics, pharmacodynamics of commonly used analgesics in liver transplantation, and its reasonable application and safety in liver transplantation recipients, hoping to provide reference for pain management in perioperative of liver transplantation.

表1 基于药物代谢动力学参数的镇痛药物分类
表2 阿片类药物代谢动力学参数和代谢途径
1
Chen JP,Jawan B,Chen CL, et al. Comparison of postoperative morphine requirements in healthy living liver donors, patients with hepatocellular carcinoma undergoing partial hepatectomy, and liver transplant recipients[J]. Transplant Proc, 2010, 42(3): 701-702.
2
Moretti EW,Robertson KM,Tuttle-Newhall JE, et al. Orthotopic liver transplant patients require less postoperative morphine than dopatients under going hepatic resection[J]. J Clin Anesth, 2002, 14(6): 416-420.
3
Donovan KL,Janicki PK,Striepe VI, et al. Decreased patient analgesic requirements after liver transplantation and associated neuropeptide levels[J]. Transplantation, 1997, 63(10): 1423-1429.
4
Rahimzadeh P,Safari S,Faiz SH, et al. Anesthesia for patients with liver disease[J]. Hepat Mon, 2014, 14(7): e19881.
5
Imani F,Motavaf M,Safari S, et al. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations[J]. Hepat Mon, 2014, 14(10): e23539.
6
Palatini P,De Martin S. Pharmacokinetic drug interactions in liver disease: An update[J]. World J Gastroenterol, 2016, 22(3): 1260-1278.
7
Huet PM,Villeneuve JP. Determinants of drug disposition in patients with cirrhosis[J]. Hepatology, 1983, 3(6): 913-918.
8
Moore JK,Love E,Craig DG, et al. Acute kidney injury in acute liver failure: a review[J]. Expert Rev Gastroenterol Hepatol, 2013, 7(8): 701-712.
9
Delco F,Tchambaz L,Schlienger R, et al. Dose adjustment in patients with liver disease[J]. Drug Saf, 2005, 28(6): 529-545.
10
Jin SJ,Jung JY,Noh MH, et al. The population pharmacokinetics of fentanyl in patients undergoing living-donor liver transplantation[J]. Clin Pharmacol Ther, 2011, 90(3): 423-431.
11
Feltracco P,Carollo C,Barbieri S, et al. Pain control after liver transplantation surgery[J]. Transplant Proc, 2014, 46(7): 2300-2307.
12
Vidhya Malar H. Beware of paracetamol toxicity[J]. J Clin Toxico, 2012, 2(6): 1000142.
13
Chou R,Gordon DB,de Leon-Casasola OA, et al. Management of postoperative pain: A Clinical Practice Guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists′ Committee on Regional Anesthesia, Executive Committee, and Administrative Council[J]. J Pain, 2016, 17(2): 131-157.
14
Hong YM,Yoon KT,Heo J, et al. The prescription pattern of acetaminophen and non-steroidal anti-inflammatory drugs in patients with liver cirrhosis[J]. J Korean Med Sci, 2016, 31(10): 1604-1610.
15
饶跃峰,王融溶,卢晓阳,等. 加速康复外科围手术期疼痛管理中非甾体抗炎药的应用进展[J]. 中华普通外科杂志,2017, 32(3): 313-315.
16
Bosilkovska M,Walder B,Besson M, et al. Analgesics in patients with hepatic impairment[J]. Drugs, 2012, 72(12): 1645-1669.
17
Orliaguet G,Hamza J,Couloigner V, et al. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol[J]. Pediatrics, 2015, 135(3): 753-755.
18
Kotb HI,Fouad IA,Fares KM, et al. Pharmacokinetics of oral tramadol in patients with liver cancer[J]. J Opioid Manag, 2008, 4(2): 99-104.
19
Miotto K,Cho AK,Khalil MA, et al. Trends in tramadol: pharmacology, metabolism, and misuse[J]. Anesth Analg, 2017, 124(1): 44-51.
20
Gasche Y,Daali Y,Fathi M, et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism[J]. N Engl J Med, 2004, 351(27): 2827-2831.
21
Latta KS,Ginsberg B,Barkin RL. Meperidine: a critical review[J]. Am J Ther, 2002, 9(1): 53-68.
22
Rudin A,Lundberg JF,Hammarlundudenaes M, et al. Morphine metabolism after major liver surgery[J]. Anesth Analg, 2007, 104(6): 1409-1414.
23
Smith HS. Opioid metabolism[J]. Mayo Clin Proc, 2009, 84(7): 613-624.
24
Riley J,Eisenberg E,Müllerschwefe G, et al. Oxycodone: a review of its use in the management of pain[J]. Curr Med Res Opin, 2008, 24(1): 175-192.
25
Tallgren M,Olkkola KT,Seppälä T, et al. Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation[J]. Clin Pharmacol Ther, 1997, 61(6): 655-661.
26
文欣荣,顾健腾,陶国才,等. 肝移植无肝期舒芬太尼的药代动力学特点[J]. 临床麻醉学杂志,2006, 22(10): 736-737.
27
Davis PJ,Cook DR. Anesthetic problems in pediatric liver transplantation[J]. Transplant Proc, 1989, 21(3): 3493-3496.
28
Hoke JF,Cunningham F,James MK, et al. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs[J]. J Pharmacol Exp Ther, 1997, 281(1): 226-232.
29
Zhang LP,Yang L,Shan-Shan BI, et al. Population pharmacokinetics of remifentanil in patients undergoing orthotopic liver transplantation[J]. Chin Med J (Engl), 2009, 122(9): 1032-1038.
30
Brachman RA,Mcgowan JC,Perusini JN, et al. Ketamine as a prophylactic against stress-induced depressive-like behavior[J]. Biol Psychiatry, 2016, 79(9): 776-786.
31
Mcgowan JC,Lagamma CT,Lim SC, et al. Prophylactic ketamine attenuates learned fear[J]. Neuropsychopharmacology, 2017, 42(8): 1577-1589.
32
Kaye AD,Kaye AM,Urman RD. Essentials of pharmacology for anesthesia, pain medicine, and critical care[M]. New York: Springer, 2015:159-161.
[1] 宋玟焱, 杜美君, 陈佳丽, 石冰, 黄汉尧. 唇腭裂手术围手术期疼痛管理的研究进展及基于生物材料治疗新方法的展望[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 397-405.
[2] 陈进宏. 腹腔镜活体供肝获取规范与创新[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 324-324.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国活体肝移植供者微创手术技术指南(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 241-252.
[4] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[5] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[6] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[7] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[8] 张斌, 孙代宇, 胡昕, 韩菲, 李久明, 李功雨, 吴伟力, 冯宝富, 彭国辉. 评分系统预测不同经验手术者输尿管软镜术后结石清除率准确性的比较研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 353-360.
[9] 黄建朋, 邹建强, 宗华. 肝移植术后腹壁疝诊治初步经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 471-473.
[10] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[11] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[12] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[13] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[14] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[15] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?